Categories | Baseline (N = 1015) | Six-months | |
---|---|---|---|
Controlled (N = 752) | Not Controlled (N = 248) | ||
# of antihypertensive medicines | |||
 0 | 976 (96.2%) | - | - |
 1 | 39 (3.8%) | 163 (21%) | 12 (5%) |
  >  = 2 | - | 587 (79%) | 236 (95%) |
Protocol medicines and daily dose | |||
 Amlodipine 5 mg | 28 | 533 (90%) | 61 (10%) |
 Amlodipine 10 mg | 11 | 216 (54%) | 182 (46%) |
 Valsartan 80 mg | - | 569 (79%) | 149 (21%) |
 Valsartan 160 mg | - | 21 (19%) | 88 (81%) |
 Hydrochlorothiazide 12.5 mg | - | - | - |
Medicine combination by Protocol step | |||
 Step 1. Amlodipine 5 mg | - | 151 (20%) | 6 (2%) |
 Step 2. Amlodipine 5 mg + Valsartan 80 mg | - | 381 (50%) | 55 (22%) |
 Step 3. Amlodipine 10 mg + Valsartan 80 mg | - | 186 (25%) | 93 (38%) |
 Step 4. Amlodipine 10 mg + Valsartan 160 mg | - | 20 (3%) | 88 (35%) |
 Step 5. Amlodipine 10 mg + Valsataran  160 mg + Hydrochlorothiazide 12.5 mg | - | - | - |
 Other | - | 12 (2%) | 6 (2%) |